High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma

Plasma lipid levels and colorectal adenoma risk

(2015) John-Anthony Coppola et al.   CANCER CAUSES & CONTROL

An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality

(2015) Ki-Chul Sung et al.   HEART

Development of esophageal cancer in Chaoshan region, China: Association with environmental, genetic and cultural factors

(2015) W.R. Tang et al.   INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH

A three-protein signature and clinical outcome in esophageal squamous cell carcinoma

(2015) Hui-Hui Cao et al.   Oncotarget

APOA1 mRNA Expression in Ovarian Serous Carcinoma Effusions Is a Marker of Longer Survival

(2014) Helene Tuft Stavnes et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis

(2014) Changying Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma

(2014) Xin Zheng et al.   BMC CANCER

Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma

(2014) Rou Jiang et al.   MEDICAL ONCOLOGY

NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma

(2014) Guan-qing Chen et al.   MEDICAL ONCOLOGY

Lipid levels in serum and cancerous tissues of colorectal cancer patients

(2014) Xin Zhang   WORLD JOURNAL OF GASTROENTEROLOGY

The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects

(2013) Maryam Zamanian-Daryoush et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Comparison of apoA-I helical structure and stability in discoidal and spherical HDL particles by HX and mass spectrometry

(2013) Palaniappan Sevugan Chetty et al.   JOURNAL OF LIPID RESEARCH

The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics

(2013) Pedro M. R. Cruz et al.   Frontiers in Pharmacology

Tyrosine-Protein Phosphatase Nonreceptor Type 12 Is a Novel Prognostic Biomarker for Esophageal Squamous Cell Carcinoma

(2012) Xun Cao et al.   ANNALS OF THORACIC SURGERY

Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma

(2012) Chun-Liang Tung et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

HDL Mimetics Inhibit Tumor Development in Both Induced and Spontaneous Mouse Models of Colon Cancer

(2012) Feng Su et al.   MOLECULAR CANCER THERAPEUTICS

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

(2010) F. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Afamin and Apolipoprotein A-IV: Novel Protein Markers for Ovarian Cancer

(2009) H. Dieplinger et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Proteomic identification of serum biomarkers for head and neck cancer surveillance

(2009) Christine G. Gourin et al.   LARYNGOSCOPE

Helical structure and stability in human apolipoprotein A-I by hydrogen exchange and mass spectrometry

(2009) Palaniappan Sevugan Chetty et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery

(2007) Kishor M. Wasan et al.   NATURE REVIEWS DRUG DISCOVERY